About conolidine

Andy Chevigné and his group, RTI-5152-12 is postulated to increase the levels of opioid peptides that bind to classical opioid receptors while in the brain, leading to heightened painkilling activity. The LIH-RTI study teams set up a collaboration agreement and submitted a joint patent ap
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15